- Citations, last 5 years
- 74.3k
- Works, last 5 years
- 5 794
- h-index
- 1,073
- Scientists listed
- 1 131
- Grants since 2016
- 2 609
Grants received
2020–2022 · research · R21
Impact of prenatal opioid exposure on long-range brain circuit connectivity and behavior
Courtney A Miller · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · cooperative agreement · U19
Consortium for Viral Systems Biology (CViSB)
Kristian Graugaard Andersen · Scripps Research Institute · funded by National Institutes of Health
2020–2023 · research · R21
Examining the Role of Circulating Endocannabinoids in Predicting Alcohol Relapse Risk and Resiliency
Barbara J Mason · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · fellowship · F31
Developing chemoproteomic approaches to decipher the regulatory network of LRH-1, a nuclear receptor implicated in hepatic metabolism
Valentine Virginie Courouble · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R21
Distinguishing plasminogen-dependent and plasminogen-independent roles of the plasminogen receptor, Plg-RKT
Lindsey A Miles · Scripps Research Institute · funded by National Institutes of Health
2020–2024 · research · R01
Molecular mechanisms of transthyretin amyloidosis
Peter Edwin Wright · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R01
AAV-mediated delivery of eCD4-Ig for prevention and treatment of perinatal HIV infection
Mauricio De Aguiar Martins · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R56
Cell type influence on exosome signaling and early pathologic signatures in Alzheimers disease
Kristin Kay Baldwin · Scripps Research Institute · funded by National Institutes of Health
2020 · research · R01
CAR T CELLS ENGINEERED TO KILL HIV-INFECTED CELLS WHILE SECRETING BROADLY NEUTRALIZING ANTIBODIES
Brian Lawson · Scripps Research Institute · funded by National Institutes of Health
2020–2024 · research · R01
Covalent Inhibition as a Method to Counteract Botulinum Intoxication
Kim Janda · Scripps Research Institute · funded by National Institutes of Health
2020–2025 · research · R35
Defining Genome Stability Mechanisms and their Regulation by SUMO and Ubiquitin
Michael N Boddy · Scripps Research Institute · funded by National Institutes of Health
2020–2025 · research · R35
Dissecting the Mechanisms of Regulation and Quality Control in Ribosome Assembly and the Consequences of their Failure
Katrin Karbstein · Scripps Research Institute · funded by National Institutes of Health
2020–2023 · research · R21
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
James Even Voss · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R21
Development of selective chemical tools to investigate sialyltransferases and sialoside products
Corwin Michael Nycholat · Scripps Research Institute · funded by National Institutes of Health
2020–2024 · grant · Continuing Grant
CAS: Expanding Base Metal-Catalyzed MHAT Reactions
Ryan Shenvi · Scripps Research Institute · funded by National Science Foundation
2020–2023 · grant · Standard Grant
Modular Synthesis of N-Glycans and Homogeneous Glycoproteins
Chi-Huey Wong · Scripps Research Institute · funded by National Science Foundation
2020–2024 · research · R01
Expediting elicitation of HIV-1 bnAbs with membrane Env vaccines
Michael B Zwick · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · Cottrell Scholar Award
Cottrell Scholar - Keary Engle (Chemistry, 2020)
Keary Engle · Scripps Research Institute · funded by Research Corporation for Science Advancement
2020–2022 · cooperative agreement · U19
Systems Approach to Immunity and Inflammation
Richard J Ulevitch · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R21
Modeling xenobiotic-induced autoimmunity using Collaborative Cross strains.
Kenneth Michael Pollard · Scripps Research Institute · funded by National Institutes of Health
2020 · research · T-PEP
Reducing tau burden by targeting its RNA with small molecules
Matthew Disney · Scripps Research Institute · funded by Alzheimer's Association
2020–2023 · grant · Continuing Grant
D3SC: GOALI: Development of a Temperature Scanning Reaction Protocol for Pharmaceutical Catalytic Reaction Screening and Optimization
Donna Blackmond · Scripps Research Institute · funded by National Science Foundation
2020–2025 · research · R01
The dark side of addiction: Significance of environmental conditioning to negative reinforcement by EtOH in subjects with a dependence history
Friedbert Weiss · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · career development · K99
A universal high-throughput platform to improve biological functions of small molecules
Seiya Kitamura · Scripps Research Institute · funded by National Institutes of Health
2020–2023 · grant · OT2
Expanding the landscape of Translator Knowledge Providers using BioThings SDK and SmartAPI
Chunlei Wu · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R21
Novel circuit mechanism of alcohol dependence vulnerability following early-life adversity
Candice Contet · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · career development · K99
A universal high-throughput platform to improve biological functions of small molecules
Seiya Kitamura · Scripps Research Institute · funded by National Institutes of Health
2020–2024 · research · R01
UNDERSTANDING HEPATIC PROTEOSTASIS IN SYSTEMIC AMYLOID DISEASES
George J Murphy · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R21
Extending the limits of cryo-EM to better understand TTR misfolding and aggregation
Gabriel C Lander · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R21
Examining the Role of Circulating Endocannabinoids in Predicting Alcohol Relapse Risk and Resiliency
Barbara J Mason · Scripps Research Institute · funded by National Institutes of Health
2020–2021 · research · R21
Adaptations to chronic activation of BK channels by ethanol: Contribution to dependence and tolerance
Candice Contet · Scripps Research Institute · funded by National Institutes of Health
2020–2021 · fellowship · Postdoctoral Fellowship
Probing the Aggregation Pathway of Human Transthyretin
Xun Sun · Scripps Research Institute · funded by American Heart Association
2020–2022 · research · R35
Design of precision small molecules targeting RNA repeating transcripts to manipulate and study disease biology
Matthew D Disney · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · research · R21
Distal gut microbiome targets of host anti-proteolytic proteins during colitis
Howard C Hang · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · grant · OT2
Expanding the landscape of Translator Knowledge Providers using BioThings SDK and SmartAPI
Chunlei Wu · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · grant · High Impact Pilot Award
Enzyme-Based Antidotal Approach for the Treatment of Acute Nicotine Toxicity
Kim Janda · Scripps Research Institute · funded by Office of the President, University of California
2020–2022 · fellowship · F32
Unraveling the mechanism by which Rps26-deficient ribosomes form to support the stress response
Jason Yoon-Mo Yang · Scripps Research Institute · funded by National Institutes of Health
2020 · fellowship · F32
Quantitation and Characterization of Cysteine Modifications in Parkinson's Disease Due to Reactive Oxygen and Nitrogen Species
Matthew Edward Albertolle · Scripps Research Institute · funded by National Institutes of Health
2020–2022 · grant · LCRP
A Chemical Proteomic Strategy for Mapping Codependency Pathways in KRAS-Driven Lung Cancer
Christopher Parker · Scripps Research Institute · funded by Congressionally Directed Medical Research Programs
2020–2025 · research · R01
Non-immunosuppressive Sanglifehrin Analogs as Therapeutic Agents for Viral Hepatitis-induced Liver Damage Development
Philippe Andre Gallay · Scripps Research Institute · funded by National Institutes of Health
